Geenitehnoloogia konverents 2000
Sissejuhatus Programm Esinejad Osalejad Osavõtutingimused Registreeru
konverents
Prof C.Thomas Caskey MD
President and CEO, Cogene BioTech Ventures, Inc.
Trustee and President, The Merck Genome Research Institute
Mart Laar
Prime Minister, Republic of Estonia

Max Baur
Department for Medical Biometry, Informatics and Epidemiology, University of Bonn, Germany
Prof Elmars Grens
Biomedical Research and Study Centre, University of Latvia
Dr. Pavel S. Gromov
Danish Centre for Human Genome Research, University of Aarhus
Marc Grovic
Portfolio Manager, Small Enterprise Assistance Funds (SEAF), USA

Prof Arvydas Janulaitis
University of Vilnius
Dr. Bartha Maria Knoppers

Chairwoman, Ethical, Legal & Social Issues Committee of the Human Genome Project
Prof Anne-Brit Kolsto
Biotechnology Centre of Oslo, University of Oslo 
Dr. Milan Macek
Department of Medical Genetics, University Hospital, Praque
Prof Andres Metspalu
Chair of Biotechnology, Tartu University, Estonia 
Dr. Douglas S. Montgomery

Clinical Genetics Collaborations Facilitator, Glaxo - Wellcome
Prof Hans Prydz
Biotechnology Centre of Oslo, University of Oslo 

Prof Elio Riboli 
Chief, Unit of Nutrition and Cancer International Agency for Research on Cancer, Lyon, France

Prof Mart Saarma
The Institute of Biotechnology, University of Helsinki 
Dr. Killu Tõugu Sanborn
Associate, IngleWood Ventures, USA
Prof Peeter Tulviste
Chairman of the Tartu City Council
Former Rector Magnificus of University of Tartu

Prof Mathias Uhlen
The Royal Institute of Technology, Stockholm 
Prof Richard Villems
The Estonian Biocentre, Tartu University, Estonia 
Dr. Jaak Vilo
European Bioinformatics Institute (EBI), Hinxton, Cambridge

Biotech Start-ups

Asper Ltd.
InBio Ltd.
LabAs Ltd. 
Quattromed Ltd.
Solis Biodyne Ltd.
Visgenyx Ltd.
Vulpes Ltd.